Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinom”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06972758
What this trial is testing

Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)

Who this might be right for
CarcinomHepatocellular
Yonsei University 60
Testing effectiveness (Phase 2)Study completedNCT04929080
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC

Who this might be right for
Head and Neck Squamous Cell CarcinomNasopharyngeal Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 149
Large-scale testing (Phase 3)Active Not RecruitingNCT06506955
What this trial is testing

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Who this might be right for
Advanced/Metastatic Cancer
Taiho Oncology, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT06440187
What this trial is testing

Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinom
Seoul National University Hospital 38
Testing effectiveness (Phase 2)Looking for participantsNCT07239596
What this trial is testing

Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom

Who this might be right for
Advanced Renal Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 92
Not applicableStudy completedNCT05568576
What this trial is testing

Metabolic Syndrome and Long-term Survival Following Liver Resection

Who this might be right for
Survival
Assiut University 70
Large-scale testing (Phase 3)Looking for participantsNCT06190782
What this trial is testing

Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic DiseaseRadiotherapy
Fudan University 354
Large-scale testing (Phase 3)Study completedNCT03413579
What this trial is testing

Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom

Who this might be right for
Cervical Cancer
El Kendi Pharmaceuticals Manufacturing Company 37
Not applicableActive Not RecruitingNCT06770699
What this trial is testing

Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Jiangxi Provincial Cancer Hospital 260
Not applicableStudy completedNCT01518829
What this trial is testing

Procalcitonin in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ain Shams University 42
Not applicableNot Yet RecruitingNCT07206511
What this trial is testing

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

Who this might be right for
Unresectable Hepatocellular Carcinom
Shanghai Zhongshan Hospital 278
Not applicableLooking for participantsNCT07704489
What this trial is testing

San Raffaele Registry on Liver Cancer

Who this might be right for
Liver and Intrahepatic Biliary Tract Cancer
IRCCS San Raffaele 4,000
Post-approval studies (Phase 4)UnknownNCT05782764
What this trial is testing

Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom

Who this might be right for
Lung Squamous Cell Carcinoma
Xuzhou Medical University 30